Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
07/29/2004 | US20040146854 Attenuated forms of bovine viral diarrhea virus |
07/29/2004 | US20040146846 Storage and maintenance of blood products including red blood cells and platelets |
07/29/2004 | US20040146530 Avian vaccine effective against infectious bursal disease virus |
07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
07/29/2004 | US20040146490 Antibacterial therapy for multi-drug resistant bacteria |
07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
07/29/2004 | DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor |
07/29/2004 | CA2513025A1 Dual expression vector system for antibody expression in bacterial and mammalian cells |
07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
07/28/2004 | EP1440149A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
07/28/2004 | EP1439856A1 Recombinant rabies vaccine and methods of preparation and use |
07/28/2004 | EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
07/28/2004 | CN1516733A Materials and methods relating to increasing viral titre |
07/27/2004 | US6767699 Viral purification; mix viral preparation and ion exchange resins, remove unbound viral particles, elute bound viral particles, recover preferential replicon |
07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
07/24/2004 | CA2418004A1 Multiplex assays for detection and identification of viral respiratory pathogens |
07/22/2004 | WO2004061093A1 Immunizing fish against viral infection |
07/22/2004 | WO2004060912A2 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes |
07/22/2004 | WO2003085084A3 Hepatitis c virus sub-genomic replicons |
07/22/2004 | WO2003077853A9 Immortal porcine cells |
07/22/2004 | WO2003039477A3 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
07/22/2004 | WO2003031583A3 Generation of virus-like particles by vsv |
07/22/2004 | US20040142476 Organellar targeting of RNA and its use in the interruption of environmental gene flow |
07/22/2004 | US20040142470 Recombinase-based system for construction of adenovirus vectors |
07/22/2004 | US20040142451 one linker, a biomolecule coupled to the linker, and cyclohexane derivatives |
07/22/2004 | US20040142449 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
07/22/2004 | US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance |
07/22/2004 | US20040142004 Avian pneumovirus vaccine |
07/22/2004 | US20040142003 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
07/22/2004 | US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
07/21/2004 | EP1438969A1 Arterivirus marker vaccine |
07/21/2004 | EP1438399A2 Paramyxoviruses as gene transfer vectors to lung cells |
07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
07/21/2004 | EP1438066A1 Incapacitated whole-cell immunogenic bacterial compositions |
07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
07/21/2004 | CN1514734A Composition and method for increasing cell density in cell cultures infected with lentivirus |
07/21/2004 | CN1514688A Oncolytic virus therapy |
07/21/2004 | CN1513996A Marek's disease virus vaccine CV1988 strain VP22 gene |
07/21/2004 | CN1513987A Recombination pseudorabies virus for expressing pig breeding and respiration comproehensive oyndrome virus and application |
07/21/2004 | CN1513553A Vero cell fick-borne encephalitis inactivated vaccine |
07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
07/20/2004 | US6764685 Chimeric viruses; cdna or rna used to express heterologous gene products in host cell systems and/or to rescue negative strand rna recombinant viruses |
07/20/2004 | US6764684 Avian herpesvirus-based recombinant infectious bursal disease vaccine |
07/20/2004 | US6764676 Attenuated fiv-141 virus with deletion mutation in the env gene; vaccines; replicates upon entry to host cell |
07/15/2004 | WO2004058953A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
07/15/2004 | WO2004058801A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
07/15/2004 | WO2004034956A3 8-plasmid method with mutated ha gene for producing an influenza vaccine |
07/15/2004 | WO2004027048A3 High titer recombinant aav production |
07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
07/15/2004 | WO2003093431A3 Ablated slam-dependent entry |
07/15/2004 | WO2003089612A3 IMPROVED rAAV VECTORS |
07/15/2004 | US20040137627 Using sendai viral vector as tool for transfer and expression of heterologous nucleotide sequences |
07/15/2004 | US20040137599 Leporipox-based vector vaccines |
07/15/2004 | US20040137015 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
07/15/2004 | US20040137013 Live vaccine and method of manufacture |
07/15/2004 | US20040136963 Simian adenovirus vectors and methods of use |
07/15/2004 | US20040136962 Ordered molecular presetation of antigens, method of preparation and use |
07/15/2004 | CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
07/15/2004 | CA2511243A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
07/14/2004 | EP1437593A1 Method of examining (-)-strand rna virus vector having lowered ability to form grains and method of constructing the same |
07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
07/14/2004 | EP1436058A1 Separation medium, its preparation and its use |
07/14/2004 | EP1436056A2 Macroporous gel, its preparation and its use |
07/14/2004 | EP1436001A1 Chicken anemia virus vaccine from cell line |
07/14/2004 | EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity |
07/14/2004 | EP0954566B1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
07/14/2004 | CN1511947A Gene expression preventing chronic transplanting rejection of recombined gland relative virus mediated haem oxidase-1 (HO-1) |
07/14/2004 | CN1511587A Process for preparing Vero cell epidemic cold purified vaccine and its use |
07/14/2004 | CN1157479C Virus expression veclor of tomato flower-leaf virus low virulent strain K |
07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
07/13/2004 | US6762031 Viral expression library for use as tools in gene therapy |
07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
07/13/2004 | CA2163212C Therapeutic compounds |
07/13/2004 | CA2118862C Bovine ovary cell line (frov) for virus replication |
07/08/2004 | WO2004057021A2 Molecular methods and compositions for detecting and quantifying respiratory viruses |
07/08/2004 | WO2004056979A2 Recombinant virus production for the manufacturing of vaccines |
07/08/2004 | WO2004056977A1 Production of alvac on avian embryonic stem cells |
07/08/2004 | WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor |
07/08/2004 | WO2004003143A3 Viruses and virus-like particles for multiple antigen and target display |
07/08/2004 | WO2002081655A3 Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo |
07/08/2004 | US20040133942 Comprises insecticidal protein against lepidopteran insect pests; biological pest control and tissue engineering |
07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
07/08/2004 | US20040132678 Recombinant double-stranded RNA phage, and use of the same |
07/08/2004 | US20040132178 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
07/08/2004 | US20040132162 Chimeric papillomavirus-like particles |
07/08/2004 | US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
07/08/2004 | US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
07/08/2004 | US20040132007 Modified virus |
07/08/2004 | US20040131640 Escape mutants of newcastle disease virus as marker vaccines |
07/08/2004 | US20040131639 Novel recombinant tryptophan mutants of influenza |
07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
07/08/2004 | US20040131592 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine |
07/08/2004 | US20040131497 Process for sterilization of biological compositions containg protein |
07/08/2004 | DE10221411B4 Rekombinantes Fowlpox-Virus Recombinant fowlpox virus |
07/08/2004 | CA2510229A1 Production of alvac on avian embryonic stem cells |
07/08/2004 | CA2501975A1 Recombinant virus production for the manufacturing of vaccines |
07/07/2004 | EP1435387A1 The oncolytic microorganisms expressing hsp and uses thereof |